Objective
A venture capital firm wanted to an in-depth situational analysis of the immuno-oncology market primarily focusing on the US and EU markets. The objective of the study was to have an overview of the market attractiveness and to identify investment opportunities in early-stage therapies.
Approach
Extensive secondary research was conducted to understand the different types of Immuno-oncology therapies in the market, indications, commercialized and pipeline products, key brands, the revenue of brands, valuation of pipeline drugs, on-going clinical trials, regulatory updates, reimbursement in the US & EU, company profiles and key deals.
Outcome
The client was able to utilize the information for their strategic business objective of taking a decision to enter the Immuno oncology market.